Board of Management report and upcoming ECHAMP publications
RSS feed
How is it that this comparatively small and emerging sector is able to fill the headlines so regularly? Homeopathy has always been the subject of public debate and from its inception has provoked scientific disputes. This is an intrinsic outcome of its specific paradigms, which are increasingly supported by good data. Scientific debate is important. However, it is increasingly clear that some actors in this debate base their arguments on false information and unscientific methods, with an increasing intention of influencing policy making on homeopathic medicinal products. This article provides a round-up of news on homeopathy that has been recently in the public eye, both constructive and negative, bringing you up to date with the latest stories and giving you access to the often hidden facts behind the headlines.
World Integrated Medicine Forum on the Regulation of Homeopathic Medicinal Products: Advancing Global Collaborations (Goa, India) and potential revision of Directive 2001/83/EC by the future new Commission.
The second World Integrated Medicine Forum in Goa addressed the topic of global collaboration on the regulation of homeopathic medicinal products.
A new animation from Homeopathy Research Institute demonstrates the global impact of NHMRC's flawed 2015 report on homeopathy and how this inaccurate research in Australia is damaging homeopathy worldwide.
An international conference in Strasbourg, 19-20 June, hosted by EDQM, will address all aspects of the quality of medicines and help pave the way for the future European Pharmacopoeia.
HMPWG has published five new finalised documents on its website – on first safe dilutions, nosodes and a recent meeting report.
The Homeopathic Medicinal Products Working Group of the Heads of Medicines Agencies (HMPWG) has released three new documents for public consultation – two with questions and answers on the quality of homeopathic medicinal products, and the fifth list of first safe dilutions. ECHAMP explains briefly the content of these documents and invites members to submit their comments to the office by 27th February.
New publication 'The EU Market for Homeopathic and Anthroposophic Medicinal Products 2018', response to the public consultation 'Questions and Answers Document on the Quality of Homeopathic Medicinal Products (Q10)'
to the public consultations on the “Questions and Answers Document on the Quality of Homeopathic Medicinal Products (Q10)”
Two new market surveys confirm solid support for homeopathy amongst patients in France and in Italy.
New publication - The EU Market for Homeopathic and Anthroposophic Medicinal Products 2018 and new social media campaign: "Release the First report"
European Antibiotic Awareness Day on 18 November: New materials from EUROCAM put a spotlight on the role of CAM in reducing the problem of antimicrobial resistance.
The Regulation of Homeopathic Medicinal Products; Advancing Global Collaboration
Meeting with the Homeopathic Medicinal Products Working Party of the Heads of Medicines Agencies
Your comments are requested on the new HMPWG consultation "Questions and Answers Document on the Quality of Homeopathic Medicinal Products (Q10)". ECHAMP’s deadline for comments is 31 October 2018.
Occasionally carefully researched, often misrepresented, homeopathy is never far from the limelight. Co-ordinated challenges to the sector are being countered by increasingly active campaigns from those who use and benefit from the medicines and therapies. Read on for our triannual round up of some of the key stories about homeopathy and anthroposophic medicine that have cropped up in the European media in recent months.
Evaluation of the HMPWG Report on the Regulatory Status of Homeopathic Medicinal Products for Human Use in EU And EFTA Countries, update on the Australian report campaign
A new position paper from ECHAMP outlines an irregular, inconsistent and illegal change in the pharmacovigilance obligations for manufacturers of homeopathic medicinal products in the EU.
Homeopathic medicinal products are now included in the range of medicines for which the European Union (EU) and Japan agree to recognise each other’s inspections of manufacturing sites.
Open letter to the President of the Spanish Government concerning the registration process, comments to the public consultation on "Study supporting the Evaluation of the European Medicines Agency Fee System", update on the Australian report campaign
Movie "Just one drop", Comments on the 2nd list of FSD
Add your company’s voice to an international campaign to make NHMRC accountable for its actions in publishing the inaccurate and damaging Homeopathy Review
to the "Preamble to the consolidated list of justified homeopathic stocks"
to the "fourth list entries of stocks for which homeopathic use is justified”
At its annual Membership Assembly in Marseille on 17 April, ECHAMP was pleased to welcome its first extraordinary partner, the homeopathic medicine company Schmidt Nagel from Switzerland.
Task ECHAMP office assistant
Concerning the registration process in Spain
The pharmacovigilance requirements shall apply to homeopathic medicinal products, with the exception of homeopathic medicinal products registered further to the special, simplified registration procedure under Article 14(1) of Directive 2001/83/EC.
A new global campaign, ‘Release the First Report,’ invites the international community to put pressure on the Australian government to correct the mistake it made when the Australian National Health and Medical Research Council (NHMRC) published its 2015 information paper on homeopathy.